Background Young women wishing to become living kidney donors frequently ask whether
nephrectomy will affect their future pregnancies. Methods We conducted a retrospective …

Objective To examine risk of malignancy and death in patients with kidney transplant who
receive the immunosuppressive drug sirolimus. Design Systematic review and meta-analysis …

Blockade of the renin-angiotensin system with either an angiotensin-converting enzyme (ACE)
inhibitor or an angiotensin receptor blocker (ARB) was shown to decrease urinary protein …

ABSTRACT. Mycophenolate mofetil (MMF) significantly decreases acute rejection rates after
renal transplantation, but intolerance often occurs, leading to dose reduction. The clinical …

The incidence and prevalence of heart failure (HF) and chronic kidney disease (CKD) are
increasing, and as such a better understanding of the interface between both conditions is …

Objective: To compare tacrolimus with cyclosporin for immunosuppression in renal
transplantation. Design: Meta-analysis of randomised trials of two treatments after kidney …

Background. Polyomavirus-associated nephropathy (PVAN) is an important cause of kidney
graft loss but there is no consensus on its management. This study aimed to systematically …

The end-stage renal disease population is aging. Nearly half of all new patients are older
than 65 years and one third are older than 70 years. Assessing the possibility of …

Accurate measurement of GFR is critical for the evaluation of new therapies and the care of
renal transplant recipients. Although not accurate in renal transplantation, GFR is often …

Hepatitis C virus (HCV) infection is common in end-stage renal failure patients. It is not known
whether the prognosis of HCV-positive patients differs depending on whether they remain …